Autonomix Medical, Inc.
AMIX
$0.44
-$0.02-4.38%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -4.93% | 210.89% | 1.61% | -6.93% | -23.87% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 21.70% | 165.66% | 24.26% | 34.60% | -6.05% |
| Operating Income | -21.70% | -165.66% | -24.26% | -34.60% | 6.05% |
| Income Before Tax | -20.24% | -165.44% | -23.64% | 40.99% | 12.88% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -20.24% | -165.44% | -23.64% | 40.99% | 12.88% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -20.24% | -165.44% | -23.64% | 40.99% | 12.88% |
| EBIT | -21.70% | -165.66% | -24.26% | -34.60% | 6.05% |
| EBITDA | -23.67% | -169.87% | -26.13% | -35.19% | 7.29% |
| EPS Basic | 75.14% | 39.46% | 51.21% | 75.06% | 52.30% |
| Normalized Basic EPS | 75.13% | 39.46% | 51.21% | 75.06% | 52.30% |
| EPS Diluted | 75.14% | 39.46% | 51.21% | 75.06% | 52.30% |
| Normalized Diluted EPS | 75.13% | 39.46% | 51.21% | 75.06% | 52.30% |
| Average Basic Shares Outstanding | 383.60% | 338.44% | 153.40% | 136.55% | 82.63% |
| Average Diluted Shares Outstanding | 383.60% | 338.44% | 153.40% | 136.55% | 82.63% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |